Effect of Estrogen-Progestin Replacement Therapy on Plasma Lipids and Lipoproteins in Postmenopausal Women

References

• Myers L. S., Dixen J., Morrissette D., Carmichael M., Davidson J. M. Effects of estrogen, androgen, and progestin on sexual psychophysiology and behavior in postmenopausal women. J Clin Endocr Metab 1990; 70: 1124–1131
   PubMed Web of Science ®Google Scholar
• Sotelo M. M., Johnson S. R. The effect of hormone replacement therapy on coronary heart disease. Endocrinology and Metabolism of North America 1997; 26(2)313–328
   PubMed Web of Science ®Google Scholar
• Grodstein F., Stampfer M. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog Cardiovasc Dis 1995; 38: 192–210
   Web of Science ®Google Scholar
• Ortega E., Cuadros J. L., Gonzalez A. R., Ruiz E. Effects of estrogen-progestin replacement therapy on plasma beta endorphin levels in menopausal women. Biochem Mol Biol Inter 1993; 29(5)831–836
   PubMedGoogle Scholar
• Stampfer M. J., Colditz G. A. Estrogen replacement therapy and coronary heart disease. A quantitative assessment of the epidemiologic evidence. Prey Med 1991; 20: 47–63
   PubMed Web of Science ®Google Scholar
• Smith D. C., Prentice R., Donovan JT, et al. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med 1975; 293: 1164–1167
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal estrogen/progestin intervention (PEPI) Trial. JAMA 1996; 275: 370–375
   PubMed Web of Science ®Google Scholar
• Fahraeus L. The effects of estradiol on blood lipids and lipoprotein in postmenopausal women (review). Obstet Gynecol 1988; 72/5: 18S–22S
   Web of Science ®Google Scholar
• Castelo-Branco C., Martinez de Osaba M. J., Fortuny A., Iglesias X., Gonzalez-Merlo J. Circulating hormone levels in menopausal women receiving different hormone replacement therapy regimens. A comparison. J Reprod Med 1995; 40: 556–566
   PubMed Web of Science ®Google Scholar
• Brett K. M., Madans J. H. Long term survival after coronary heart disease. Comparisons between men and women in a national sample. Ann Epidemiol 1995; 5: 25–32
   PubMedGoogle Scholar
• Cauley J. A., Cumming S. R., Black DM, et al. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 163/ 1990; 5: 1438–1444
   Google Scholar
• Grodstein F., Stampfer M. J., Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 3J 1996; 5: 453–461
   Google Scholar
• Matthews K. A., Kuller L. H., Wing RR, et al. Prior to use of estrogen replacement therapy, are users healthier than nonusers?. Am J Epidemiol' 1996; 143/3: 971–978
   Web of Science ®Google Scholar
• Ettinger B., Friedmen G. D., Bush T., Quesenberry CP, Jr. Reduced mortality associated with long term postmenopausal estrogen study. Obstet Gynecol 1996; 87: 6–12
   PubMed Web of Science ®Google Scholar
• Walsh B. W., Schiff I., Rosner R., Greenberg L., Ravnikar V., Sacks F. M. Effects of postmenopausal estrogen replacement on the concentration s and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196–1204
   PubMed Web of Science ®Google Scholar
• Sack M. N., Rader D. L., Cannon R. O. Oestrogen and inhibition of oxidation of low density lipoproteins in postmenopausal women. Lancet 1994; 343: 269–270
   PubMed Web of Science ®Google Scholar
• Valverde M. A., Rojas P., Amigo J., Cosmelli D., Orio P., Vergara C., Latorre R. En busca de las bases moleculares de la vasodilatacion inducida por estrogenos. XXII Congreso de la rog Sociedad Espanola, de Bioquimica y Biologia Molecular. Pamplona 15–18 September. 1999
   Google Scholar
• Speroff L., Rowan J., Symons J, et al. The comparative effect on bone density, endometrium, and lipids of continuous hormone as replacement therapy (CHART study): A randomized controlled trial. JAMA 1996; 276: 1397–1403
   PubMed Web of Science ®Google Scholar
• Bush T. L., Miller V. T. Effects of pharmacologic agents used during menopause impact on lipids and lipoproteins. Menopause physiology and pharmacology, D Mishell, Jr. Year Book Medical, Chicago 1986; 187–208
   Google Scholar
• Sarrel PM. Blood Flow. Treatment of the postmenopausal woman: basis and clinical aspects., RA Lobo. Raven Press, New York 1994; 251–262
   Google Scholar
• Espeland MA, Marcovina S. M., Miller V., Wood P. D., Wasilauska C., Sherwin I., Schrott H., Bush T. L. Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. Circulation 1998; 97: 979–986
   PubMed Web of Science ®Google Scholar
• Wakatsuki A., Ikenoue N., Sagara Y. Estrogen-induced small low density lipoprotein particles in postmenopausal women. Obstet Gynecol 1998; 91: 234–240
   PubMed Web of Science ®Google Scholar
• Wanfang S. U., Campos H., Judge H., Wals B. W., Sacks F. M. Metabolism of Apo(a) and Apo B 100 of Lipoprotein(a) in women: Effect of postmenopausal estrogen replacement. J Clin Endocr Metab 1998; 83: 3267–3276
   PubMed Web of Science ®Google Scholar
• Ma P. T., Yamamoto T., Goldstein J. T., Brown M. S. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha ethinyl estradiol. Proc Natl Acad Sci USA 1986; 83: 792–796
   PubMed Web of Science ®Google Scholar
• Windler EE., Kovanen P. T., Chao Y. S., Brown M. S., Havel R. J., Goldstein J. L. The estradiol stimulated lipoprotein receptor of rat liver. J. Biol Chem 1980; 255: 10464–10471
   PubMed Web of Science ®Google Scholar
• Manning JM., Campos G., Edwards U., Wagner W. D., Wagner J. D., Adams MR, et al. Effects of hormone replacement modalities of low density lipoprotein composition and distribution in ovariectomized cynomolgous monkeys. Atherosclerosis 1996; 121: 217–229
   PubMed Web of Science ®Google Scholar
• Everson G. T., Fennessey P., Kern F. Contraceptive steroids alter the steady state kinetics of bile acids. J Lipid Res 1988; 121: 217–29
   Google Scholar
• Kushhwaha RS., Born KM. Effect of estrogen and progesterone on the hepatic cholesterol 7 alpha hydroxylase activity in ovariectomized baboons. Biochem Biophys Acta 1991; 1084: 300–302
   PubMedGoogle Scholar
• Arnal J. F., Clamens S., Pechet C., Negre-Salvayre A., Allera C., Girolami JPO., et al. Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production. Proc Natl Acad Sci USA 1996; 96: 4108–4113
   Google Scholar
• Akishita M., Ouchi Y., Miyoshi H., Kozaki K., Inouse S., Ishikawa M, et al. estrogen inhibits cuff-induced intimal thickening of rat femoral artery: Effects on migration and proliferation of vascular smooth muscle cells. Atherosclerosis 1997; 130: 1–10
   PubMed Web of Science ®Google Scholar
• Pugeat M., Moulin P., Cousin P., Fimbel S., Nicolas M. H., Crave J. C., Lejeune H. Interrelations between sex hormone binding globulin (SHBG) plasma lipoproteins and cardiovascular risk. J Steroid Biochem Molec Biol 1995; 53/16: 567–572
   Web of Science ®Google Scholar
• Von Schoultz B., Calstron K. On the regulation of sex hormone binding globulin: a challenge of an old dogma and outlines of an alternative mechanism. J Steroid Biochem 1989; 32: 327–329
   PubMedGoogle Scholar
• Bruschi F., Meschia M., Amicarelli F., Bologna E., Cutarelli M., Crosignani P. G. Changes in sex hormone-binding globulin plasma concentrations induced by body weight and estrogens status in perimenopausal years. Menopause 4/ 1997; 1: 28–31
   Google Scholar
• Hunt K., Vessey M., McPherson K. Mortality in a cohort of long term users of hormone replacement therapy and updated analysis. Br J Obstet Gynecol 1990; 97: 1080–1806
   PubMedGoogle Scholar
• Thompson S. G., Meade T. W., Greenberg G. The use of hormonal replacement therapy and he risk of stroke and myocardial infarction in women. J Epidemiol Community Health 1989; 43: 173–178
   PubMed Web of Science ®Google Scholar